ROCCO, ALBA
 Distribuzione geografica
Continente #
NA - Nord America 2.091
EU - Europa 987
AS - Asia 397
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 3.499
Nazione #
US - Stati Uniti d'America 2.055
CN - Cina 344
IE - Irlanda 227
IT - Italia 211
FI - Finlandia 152
UA - Ucraina 129
NL - Olanda 105
DE - Germania 76
CA - Canada 34
GB - Regno Unito 34
SE - Svezia 33
IN - India 30
CI - Costa d'Avorio 15
VN - Vietnam 13
BE - Belgio 7
EU - Europa 7
SG - Singapore 6
AU - Australia 2
DK - Danimarca 2
ES - Italia 2
MX - Messico 2
PL - Polonia 2
RS - Serbia 2
AT - Austria 1
BG - Bulgaria 1
GR - Grecia 1
IQ - Iraq 1
IR - Iran 1
LU - Lussemburgo 1
NO - Norvegia 1
NP - Nepal 1
TR - Turchia 1
Totale 3.499
Città #
Chandler 347
Princeton 155
Jacksonville 148
Millbury 140
Nanjing 115
Amsterdam 100
Boston 97
Woodbridge 88
Naples 74
Ashburn 65
Ann Arbor 62
Wilmington 62
Houston 57
Napoli 49
Beijing 46
Nanchang 37
Shenyang 33
Norwalk 32
Ottawa 32
Hebei 26
Falls Church 19
Jiaxing 19
Changsha 16
Tianjin 14
Kronberg 13
Dong Ket 12
Hangzhou 12
Dearborn 10
Boardman 9
Des Moines 9
Dublin 9
Qualiano 9
Redmond 9
Mountain View 7
Orange 7
Washington 7
Kunming 6
New York 6
Pune 6
Santa Maria Capua Vetere 6
Villaricca 6
Zhengzhou 5
Antwerpen 4
Forio 4
Indiana 4
Taizhou 4
Courcelles 3
Eindhoven 3
Formia 3
Jinan 3
Redwood City 3
Rende 3
Belgrade 2
Ciudad Juárez 2
Durham 2
Edinburgh 2
Lanzhou 2
London 2
New Orleans 2
Ningbo 2
Nürnberg 2
Rome 2
San Francisco 2
Tappahannock 2
Terzigno 2
Toronto 2
Walnut 2
Afragola 1
Atri 1
Bologna 1
Capri 1
Caserta 1
Catania 1
Gerocarne 1
Guangzhou 1
Hanoi 1
Hanover 1
Italy 1
Kathmandu 1
Lappeenranta 1
Little Hampton 1
Lodz 1
Los Angeles 1
Lurago D'erba 1
Madison 1
Madrid 1
Milan 1
Osceola 1
Oslo 1
San Diego 1
San Vicente Del Raspeig 1
Sans Souci 1
Seattle 1
Singapore 1
Sofia 1
Vienna 1
Villa Cortese 1
Warsaw 1
Yellow Springs 1
Totale 2.077
Nome #
Vascular endothelial growth factor and cyclooxygenase-2 are overexpressed in ileal pouch-anal anastomosis. 163
Is screening for and surveillance of atrophic gastritis advisable? 48
Effect of Helicobacter Pylori infection on gastric cell proliferation and genomic instability in a paediatric population of southern Italy. 47
Large Brunner's gland adenoma: Case report and literature review. 46
Diagnosis of chronic atrophic gastritis by morphometric image analysis. A new method to overcome the confounding effect of the inflammatory infiltrate. 45
Sweetened carbonated drinks do not alter upper digestive tract physiology in healthy subjects 45
Incidence and distribution of coeliac disease in Campania (Italy): 2011-2013 45
Gastrokine 1 expression in patients with and without Helicobacter pylori infection. 44
Vitamin B12 supplementation improves rates ofsustained viral response in patients chronicallyinfected with hepatitis C virus 44
CD133 and CD44 Cell surface markers do not identify cancer stem cells in primary human gastric tumors 44
Alcoholic disease: Liver and beyond 44
Gastro-duodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure 41
Adenoma carcinoma sequence in the stomach : the role of cycloxygenase-2. 41
Risk factors in gastric cancer 40
Cd133 and Cd44 Cell Surface Markers Do Not Identify Cancer Stem Cells In Primary Human Gastric Tumours 40
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: A randomized clinical trial 40
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy 39
Effects of long-term PPI treatment on producing bowel symptoms and SIBO 38
13c-aminopyrine breath test: a sentitive and reliable method to discriminate the early stage of liver cirrhosis 38
Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis. 36
Effect of Helicobacter Pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. 36
C-13-Aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C 36
Reflux oesophagitis in adult coeliac disease: beneficial effect of a gluten free diet. 34
An unusual case of high alpha-fetoprotein level and liver masses. 34
The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease 34
Review article: helicobacter pylori and molecular events in precancerous gastric lesions. 33
The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. 33
Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury 33
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. 32
Is there a link between environmental factors and a genetic predisposition to cancer? A lesson from a familial cluster of gastric cancers. 32
In vivo and in vitro studies of cytosolic phospholipase A2 expression in Helicobacter pylori infection. 32
Loss of expression of tumor suppressor p16(INK4) protein in human primary gastric cancer is related to the grade of differentiation. 32
Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis. 32
Age-specific prevalence of Helicobacter pylori infection and morphological findings of gastric mucosa. A retrospective study in a symptomatic pediatric population of southern Italy. 32
13C-Aminopyrine breath test discriminates the early stages of liver cirrhosis 32
Cell proliferation, apoptosis and DNA-ploidy of gastric mucosa in Helicobacter pylori infection 32
BIOINFORMATIC HYPOTHESIS TO PREDICT CLINICALBEHAVIOR AND PROGNOSIS OF GASTRIC CANCER 32
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome 32
13C-AMINOPYRINE BREATH TEST PREDICTS THE CLINICAL OUTCOME IN PATIENTS WITH C VIRUS-RELATED CHRONIC HEPATITIS 31
Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease 31
A RAT MODEL OF OXIDATIVE AND METABOLIC HEPATIC INJURY: THE POTENTIAL PROTECTIVE ROLE OF LACTOBACILLUS PARACASEI F19 31
Does Helicobacter Pylori play a role in inflammatory bowel disease? 30
Gastric atrophy and intestinal metaplasia changes 8 years after Helicobacter pylori eradication. A blind, randomised study. 30
Molecular alteration of gastric carcinoma. 30
Interleukin-13 mucosal production in Helicobacter pylori-related gastric diseases. 30
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. 30
CHEMOPREVENTION OF GASTRIC CANCER: ROLE OF COX-2 INHIBITORS AND OTHER AGENTS 29
Mdr1 P-glycoprotein expression in human gastric tissue: From ontogenesis to carcinogenesis 29
P-gp regulates apoptosis in gastric mucosa by interacting with bcl-xL: an in vivo and in vitro study 29
Tissue Ghrelin Level Does Not Correlate With Gastric Emptying Rate In Adult Coeliac Patients. 28
The proliferation marker Chromatin Assembly Factor-1 is of clinical value in predicting the biological behaviour of salivary gland tumours. 28
Diet, H pylori infection and gastric cancer: evidence and controversies. 27
Does the cytokine response in chronic HCV-infected subjects predict the outcome of the infection ? 27
Cox-2 and NF-KB expression in gastric mucosa is influenced by peroxisome proliferator –activated receptor-gamma polymorphisms. 27
Acquisition of Helicobacter pylori infection in childhood: a risk for gastric carcinogenesis 27
Atrophic gastritis and intestinal metaplasia reversibility after Helicobacter pylori eradication: a long term follow-up 27
Increased severity of dyspeptic symptoms related to mental stress is associated with sympathetic hyperactivity and enhanced endocrine response in patients with postprandial distress syndrome 27
Cell proliferation and genomic instability in chronic gastritis, with and without Helicobacter pylori infection, and in gastric cancer. 26
Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases 26
C-kit protein expression in Wilms' tumour: an immunohistochemical study. 25
Screening for and surveillance of gastric cancer 25
The Gut Bacteria-Driven Obesity Development 25
The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma 25
Gastrokine 1 in Helicobacter pylori-related gastric carcinogenesis: A genomic, proteomic, and immunohistochemical study 24
Angiodysplasia as a possible cause of gastrointestinal bleeding in cirrhosis and octreotide treatment. 23
Probiotics: a potential target for the prevention and treatment of steatohepatitis. 22
Cyclo-oxygenase-2 and P-glycoprotein expression in gastric cancer: a possible pathway of multidrug resistance 22
Cancer stem cell hypothesis and gastric carcinogenesis: Experimental evidence and unsolved questions 22
GASTRIC CANCER BIOLOGICAL BEHAVIOUR: FROM BIOINFORMATIC HYPOTHESIS TO MOLECULAR ANALYSIS 22
Tissue ghrelin level and gastric emptying rate in adult patients with celiac disease. 21
I livelli tessutali di grelina non correlano con il tempo di svuotamento gastrico 21
Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis. 21
Up-regulation of heparin binding epidermal growth factor-like growth factor and amphiregulin expression in Helicobacter pylori-infected human gastric mucosa. 21
P-gp protects gastric mucosa from apoptosis by interacting with bcl-xL: an in vivo and in vitro study 21
Cyclo-oxygenase-2 and P-Glycoprotein expression in gastric cancer: a possible pathway of multidrug resistance. 21
Changes of protein expression in Helicobacter pylori-infected human gastric mucosa 21
Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer. 21
NF-KB modulation and anti-apoptotic effects of IL-13 in gastric adenocarcinoma epithelial cell lines 20
Down-regulation of human Gastrokine 1 isoforms in Helicobacter pylori-related gastric carcinogenesis 20
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection 20
VITAMIN B12 SUPPLEMENTATION IMPROVES SUSTAINED-VIRAL-RESPONSE RATES IN HEPATITIS C VIRUS GENOTYPE 1B-INFECTED PATIENTS 20
Gluten free diet significantly decreases adiponectin serum levels in adult celiac disease patients 20
Gastrokine 1 in Helicobacter pylori-related gastric carcinogenesis: A genomic, proteomic, and immunohistochemical study 20
VITAMIN B12 SUPPLEMENTATION IMPROVES SUSTAINEDVIRAL-RESPONSE RATES IN HEPATITIS C VIRUS-INFECTEDPATIENTS 20
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. 19
The effects of interleukin (IL)-13 on NF-kB-related cytokine profile and cell viability in "in vitro" model 18
Gastric carcinogenesis mirrors stomach ontogenesis: expression of P-glycoprotein in human gastric tissue 18
Gastrokine 1 expression in patients with and without Helicobacter pylori infection 18
Effect of a Three-Month Treatment With Probiotics on Symptoms, Visceral Sensitivity and Inflammatory Patterns in Patients With Predominant-Diarrhea Irritable Bowel Syndrome: A Proof-of-Concept Study 18
Gut microbiota and irritable bowel syndrome 18
Gastric Emptying Time, Esophageal pH-Impedance Parameters, Quality of Life, and Gastrointestinal Comorbidity in Obese Children and Adolescents 18
Helicobacter pylori and MDR1 P-glycoprotein expression in human gastric tissue: from ontogenesis to carcinogenesis 17
Does the local cytokine response in Helicobacter pylori infected subjects predict the outcome of infection ? 17
Gastric carcinogenesis: evaluation of cell proliferation, apoptosis and DNA content, in gastritis patients with or without Helicobacter pylori infection. 17
Treatment Options for Uncomplicated Diverticular Disease of the Colon. 16
Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. 16
DNA HYPOMETHYLATION IS AN EARLY EVENT IN HP-RELATED GASTRIC CARCINOGENESIS 16
Relationship between genomic instability markers and Helicobacter pylori infection in gastric carcinogenesis 16
Histological heterogeneity and somatic mtDNA mutations in gastric intraepithelial neoplasia. 15
Gastric cancer and multidrug resistance: do cyclo-oxygenase-2 and P-glycoprotein play a role? 15
Totale 2.976
Categoria #
all - tutte 13.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201946 0 0 0 0 0 0 0 0 1 0 5 40
2019/2020578 252 27 46 21 46 12 19 3 0 52 54 46
2020/2021290 1 30 28 27 32 68 27 2 33 3 26 13
2021/2022864 4 0 0 11 0 24 3 26 233 63 155 345
2022/2023860 162 61 16 72 91 111 2 76 118 106 39 6
2023/2024370 24 80 104 45 27 37 10 40 3 0 0 0
Totale 3.652